Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q4

Clinical Immunology Communications

United StatesImmunology (Q4); Immunology and Allergy (Q4)ISSN-matched source record
Q4Ranking
—Impact Factor (year unverified)
7H-index (SCImago 2025)
0.287SJR (2025)
2021-2026Coverage

About Clinical Immunology Communications

Clinical Immunology Communications is a scholarly journal published by Elsevier Inc.. SCImago 2025 lists it in Q4, with an SJR of 0.287 and H-index of 7.

Coverage: 2021-2026. Research categories: Immunology (Q4); Immunology and Allergy (Q4).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC, CC BY-NC-ND
Peer-review processAnonymous peer review
APCNo APC reported in the DOAJ snapshot
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, Portico
Reported submission-to-publication time8 weeks on average; not a guarantee
Openly licensed content since2021 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2772-6134
ISSN-L2772-6134
Source typeJournal
Publisher / hosting organisationElsevier BV
Publisher country codeUS
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex148
Citations recorded in OpenAlex417
OpenAlex H-index10
Years represented in OpenAlex2021–2026 (not the founding or closing dates)

Topics in published research

SARS-CoV-2 and COVID-19 Research; Immunodeficiency and Autoimmune Disorders; COVID-19 Clinical Research Studies; Immune Cell Function and Interaction; Cancer Immunotherapy and Biomarkers; Long-Term Effects of COVID-19.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-01. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit